4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-025464
EVP & Chief Medical Officer sold 6,770 shares at an average $4.05 ($27,416)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Rangwala Reshma · EVP & Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-20 | Sale : show line 1 in the form 10b5-1 | −115 | $4.03 | $463 | 164,885 | D |
| 2023-04-20 | Sale : show line 2 in the form 10b5-1 | −6,655 | $4.05 | $26,953 | 158,230 | D |
| Open-market sales · 6,770 sh · avg $4.05 · $27,416 | ||||||
Loading xslF345X04/doc4.xml…